Pigmented Lesion Treatment Market

A common feature of the skin is the presence of pigmented lesions. These lesions can be benign or malignant, depending on the condition.

SEATTLE, WASHINGTON, UNITED STATES, January 3, 2022 /EINPresswire.com/ -- A common feature of the skin is the presence of pigmented lesions. These lesions can be benign or malignant, depending on the condition. The most important consideration is whether a pigmented lesion is likely to be cancerous. To confirm a diagnosis, a dermatologist should perform a skin biopsy to confirm the diagnosis. A dermatologist can also help determine the best treatment plan for a patient.

𝐂𝐥𝐢𝐜𝐤 𝐇𝐞𝐫𝐞 𝐓𝐨 𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐂𝐨𝐩𝐲 @ https://www.coherentmarketinsights.com/insight/request-sample/1089

In contrast, vascular lesions do not have parallel ridges and thus cannot be diagnosed by the skin scraping test. While most pigmented lesions are harmless, some people develop them over time, usually due to exposure to the sun, hormonal changes, or medication. While most pigmented lesions are harmless and do not require treatment, it is a good idea to have them checked periodically. If you notice a change in color or size, consult a dermatologist as soon as possible. While most pigmented lesions are not cancerous, they should be closely monitored.

Recent Developments

Major players operating in the global pigmented lesion treatment market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2016, the U.S. Food and Drug Administration approved Cynosure’s PicoSure Energy delivery system for tattoos and pigmented lesions.

Similarly, in 2014, Syneron Medical Ltd. launched PicoWay picosecond device for pigmented lesion treatment and tattoo removal at the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam.

Global Pigmented Lesion Treatment Market: Drivers

Approval and launch of new products is expected to propel growth of the global pigmented lesion treatment market over the forecast period. For instance, in September 2017, the U.S. Food and Drug Administration approved StarWalker MaQX Q-Switched laser system from Fotona for the treatment of tattoos, pigmented and vascular lesions, acne and scar revision, and permanent hair reduction.

𝐋𝐈𝐌𝐈𝐓𝐄𝐃 𝐓𝐈𝐌𝐄 𝐎𝐅𝐅𝐄𝐑 – 𝐇𝐮𝐫𝐫𝐲 𝐔𝐩!

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐀𝐧𝐝 𝐆𝐞𝐭 𝐅𝐥𝐚𝐭 𝟑𝟎% 𝐎𝐟𝐟

𝐁𝐮𝐲 𝐍𝐨𝐰 𝐰𝐢𝐭𝐡 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐟𝐨𝐫 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.coherentmarketinsights.com/insight/buy-now/1089

Moreover, high prevalence of skin cancer is also expected to propel growth of the global pigmented lesion treatment market over the forecast period. For instance, over 5.4 million cases of non-melanoma skin cancer are reported in the U.S. annually and over 3.3 million people receive treatment, according to Skin Cancer Foundation.

Market Trends

Major players operating in the global pigmented lesion treatment market are focused on approval and launch of new products to expand their product portfolio. For instance, in December 2021, LASEROPTEK Co., Ltd., a developer and manufacturer of world-class laser devices for aesthetic and medical dermatology applications, received 510(k) clearance from the U.S. Food and Drug Administration for its PicoLO Premium picosecond pulse Nd:YAG laser.

Similarly, in 2014, Lutronic Corporation launched Lutronic XT Q-Switched, frequency doubled Nd:YAG laser, known as the Spectra XT, the system includes several treatment application such as pigmented lesion, tattoo removal, melisma, pore-size reduction, and skin-rejuvenation.

Global Pigmented Lesion Treatment Market: Competitive Landscape

Major players operating in the global pigmented lesion treatment market include, Alma Lasers, Ltd., Cynosure, Inc., Cutera Inc., EL.En. S.p.A., Fotona d.d., Lynton Lasers Ltd., Lumenis Ltd., Lutronic Corporation, Solta Medical Inc., Syneron Medical Ltd., Sciton, Inc., and Strata Skin Sciences, Inc.

Global Pigmented Lesion Treatment Market: Key Developments

Major players operating in the global pigmented lesion treatment market are focused on approval and launch of new products to expand their product portfolio. For instance, in 2014, Cutera, Inc. launched two new laser systems at the 72nd American Academy of Dermatology conference.

Global Pigmented Lesion Treatment Market: Segmentation

By Laser Type:

Fractional CO2

Diode

Infrared

Alexandrite

Nd:YAG

Pulsed

Potassium-Titanyl-Phosphate

By Indication Type:

Non-melanocytic lesions

Inflammatory

Hamartomas

Benign neoplasms

Malignant neoplasms

Melanocytic lesions

Benign

Malignant

By End User

Hospitals

Skin Clinics

Others

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐎𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.coherentmarketinsights.com/insight/request-pdf/1089

𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+ +1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.